Hepatitis C in hemodialysis: Epidemiology and prevention of hepatitis C virus transmission

Contributions to Nephrology

Volumn 176, Issue , 2012, Pages 35-41

  Jadoul, Michel ^a   Barril, Guillermina ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS INFECTION; DISEASE TRANSMISSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; PREVALENCE; RENAL REPLACEMENT THERAPY; VIROLOGY;

CROSS INFECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; PREVALENCE; RENAL DIALYSIS;

EID: 84856850907     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000333761     Document Type: Article

References (30)

1. Jadoul M, Cornu C, van Ypersele de Strihou C: Non- A, non- B hepatitis in dialysis patients: diagnosis, prevention and treat-ment; in Andreucci VE, Fine LG (eds): International Yearbook of Nephrology 1992. Berlin, Springer, 1991, pp 253-270.
2. Pereira BJ, Levey AS: Hepatitis C virus infec-tion in dialysis and renal transplantation. Kidney Int 1997;51:981-999. (Pubitemid 27186522)
3. Blajchman MA, Vamvakas EC: The continu-ing risk of transfusion- transmitted infec-tions. N Engl J Med 2006;355:1303-1305.
4. Nübling M, Heiden M, Chudy M, Kress J, Seitz R, Keller- Stanislawski B, Funk MB: Experience of mandatory nucleic acid test (NAT) screening across all blood orga-nizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009;49:1850-1858.
5. Jadoul M, Cornu C, van Ypersele de Strihou C, the UCL Collaborative group: Universal precautions prevent hepatitis C virus trans-mission: a 54 month follow- up of the Belgian multicenter study. Kidney Int 1998;53:1022-1025. (Pubitemid 28155679)
6. Centers for Disease Control and Prevention. Recommendations for preventing transmis-sion of infections among chronic hemodialy-sis patients. MMWR 2001;50:RR- 5.
7. Petrosillo N, Gilli P Serraino D, Dentico P Mele A, Ragni P Puro V, Casalino C, Ippolito G: Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001;37:1004-1010. (Pubitemid 32436573)
8. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A: Incidence and patterns of hepa-titis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005;45:334-343. (Pubitemid 40431060)
9. Barril G, Traver JA: Decrease in the hepatitis C virus (HCV) prevalence in hemodialysis patients in Spain: effect of time, initiating HCV prevalence studies and adoption of iso-lation measures. Antiviral Res 2003;60:129-134. (Pubitemid 37452457)
10. Jadoul M: Should hemodialysis patients with hepatitis C virus antibodies be isolated? Semin Dial 1995;8:1-3.
11. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkodi S, Goubeau P the HCV collaborative group: The changing epi-demiology of hepatitis C virus (HCV) infec-tion in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004;19:904-909. (Pubitemid 38455663)
12. Espinosa M, Martn-Malo A, Ojeda R Santamara R, Soriano S, Aguera M, Aljama P: Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004;43:685-689. (Pubitemid 38401883)
13. KDIGO Clinical Practice Guidelines for the prevention, diagnosis, evaluation and treat-ment of hepatitis C in chronic kidney dis-ease. Kidney Int 2008;73(suppl 109):S1-S99.
14. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65:2335-2342. (Pubitemid 38670020)
15. Süleymanlar G, Serdengeçti K, Altiparmak MR, Jager K, Seyahi N, Erek E, Turkish Registry of Nephrology Dialysis, and Transplantation: Trends in renal replacement therapy in Turkey 1996-2008. Am J Kidney Dis 2011;57:456-465.
16. Sauné K, Kamar N, Miédougé M, Weclawiak H, Dubois M, Izopet J, Rostaing L: Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey. Nephrol Dial Transplant 2010;26:2309-2316.
17. Nakai S, Suzuki K, Masakane I, Wada A, et al: Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010;14:505-540.
18. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, Jha V, Wang T, Kawaguchi Y Qian J: Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 2009;24:1598-1603.
19. Bergman S, Accortt N, Turner A, Glaze J: Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005;45:684-689. (Pubitemid 40460756)
20. Ilçöl B, Ozener C, Avar M, Ilçol Y Lawrence R, Ozer A, Cirakolu B, Akolu E: Hepatitis C infection in patients with chronic renal failure receiving conservative therapy Nephrol Dial Transplant 1997;12:626. (Pubitemid 27105659)
21. López-Alcorocho JM, Barril G, Ortiz-Movilla N, Traver JA, Bartolomé J, Sanz P Selgas R, Carreño V: Prevalence of hepatitis B, hepati-tis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol 2001;63:103-107. (Pubitemid 32146153)
22. Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, Ferraz ML: Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients. Nephron Clin Pract 2008;108:c135-c140. (Pubitemid 351346937)
23. Iwasa Y Otsubo S, Sugi O, Sato K, Asamiya Y, Eguchi A, Iwasaki T, Matsuda N, Kikuchi K, Ikebe N, Miwa N, Kimata N, Uchida K, Uchida S, Nitta K, Akiba T: Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol 2008;12:53-57.
24. Kamar N, Rostaing L, Alric L: Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int 2006;69:436-439. (Pubitemid 43164433)
25. Ali I, Siddique L, Rehman LU, Khan NU, Iqbal A, Munir I, Rashid F, Khan SU, Attache S, Swati ZA, Aslam MS: Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa. Virol J 2011;8:296.
26. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, Radasan A, Micu G, Pertache I: A cross-sectional epidemiological study of HBV, HCV, HDV and HEV preva-lence in the subcarpathian and south-eastern regions of Romania. J Gastrointestin Liver Dis 2010;19:43-48.
27. El-Ottol AEY Elmanama AA, Ayesh BM: Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J 2010;7:210.
28. Bin Selm S: Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen. Saudi J Kidney Dis Transplant 2010;21:1165-1168.
29. Prati D: Transmission of hepatitis C virus by blood transfusions and other medi-cal procedures: a global review. J Hepatol 2006;45:607-616. (Pubitemid 44316867)
30. Bhattacharya S, Price N, Boxall E, Adu D, Lipkin G, Smith S, Osman H: Holiday haemodialysis and imported hepatitis C virus infection: a series of sixteen cases in two large haemodialysis units. J Clin Virol 2009;45:296-299.